𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia

✍ Scribed by Javier Pagonabarraga; Gisela Llebaria; Carmen García-Sánchez; Berta Pascual-Sedano; Alexandre Gironell; Jaime Kulisevsky


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
76 KB
Volume
23
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Delusional misidentification syndromes (DMS) are a group of neuropsychiatric disorders due to disturbances in familiarity. DMS in organic diseases have been related to deficits in executive, memory, and visuospatial function. DMS are frequently reported in dementia with Lewy bodies (DLB). The presence of DMS in Parkinson's disease with dementia (PDD), which shares similar clinical and neuropsychological features with DLB, has not been studied. We describe the frequency and clinical features of DMS in a cohort of PDD patients, and we compare the neuropsychological profile between PDD patients with and without DMS. Prospective study of 30 PDD patients recruited from an outpatient setting, who received a structured behavioral interview assessing DMS and hallucinations, and a neuropsychological battery assessing executive function, memory, language, and visuospatial abilities. DMS were found in 16.7% of PDD patients. All DMS subjects also exhibited hallucinations that were significantly more severe than in PDD without DMS. DMS were responsive to neuroleptic drugs. PDD subjects with DMS presented a different neuropsychological profile than PDD subjects without DMS, with more severe memory and language deficits, but similar levels of executive and visuospatial impairment. DMS is a neuropsychiatric feature associated with PDD. Greater impairment in language and memory in PDD with DMS suggests a prominent role of the temporal cortex in the genesis of DMS in PDD. © 2007 Movement Disorder Society


📜 SIMILAR VOLUMES


Neuropathology of dementia in Parkinson'
✍ Dag Aarsland; Robert Perry; Andrew Brown; Jan P. Larsen; Clive Ballard 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 3 views

## Abstract Twenty‐two patients with Parkinson's disease drawn from a community‐based study were followed prospectively until their deaths. Even though 18 patients had dementia, none fulfilled Braak and Braak or The National Institute on Aging and Ronald and Nancy Reagan Institute of the Alzheimer'

A validation study of depressive syndrom
✍ Sergio E. Starkstein; Marcelo Merello; Ricardo Jorge; Simone Brockman; David Bru 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## Abstract The validity, sensitivity, and specificity of depressive symptoms for the diagnosis of major depression, minor depression, dysthymic disorder, and subsyndromal depression in Parkinson's disease (PD) were examined. A consecutive series of 173 patients with PD attending a Movement Disorde

Rate of clinical progression in Parkinso
✍ Anette Schrag; Richard Dodel; Annika Spottke; Bernhard Bornschein; Uwe Siebert; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract Few prospective data on the clinical progression of Parkinson's disease (PD) in patient groups outside treatment trials in selected patients are available, and controversy exists on the rate of clinical disease progression with advancing disease. In this study, we investigated the rate

A systematic review of prevalence studie
✍ Dag Aarsland; Julia Zaccai; Carol Brayne 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract Substantial variation in the prevalence of dementia in Parkinson's disease (PDD) has been reported. The aim of this study was to review systematically and critically previous studies of the prevalence of PDD using PubMed to search the literature. Studies focusing on PD and PDD, as well

Associations between family history of P
✍ Martin Wilhelm Kurz; Jan Petter Larsen; Jan Terje Kvaloy; Dag Aarsland 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract Dementia is common in patients with Parkinson's disease (PDD). The etiology of PDD is still unclear, but exciting advances have been made in discovering pathogenetic components in Parkinson's disease (PD), implicating the role of genetic factors. It is, however, still controversial whet